As mentioned above, lowering SOD1 is being investigated as a therapeutic for SOD1 ALS given that the pathological misfolding and aggregation of mutant SOD1 are believed to underlie its toxicity [88]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.